Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout
November 11 2013 - 10:08AM
Business Wire
The securities litigation firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches
of fiduciary duty to current shareholders of ViroPharma
Incorporated (“ViroPharma” or the “Company”) (NASDAQ: VPHM)
and other violations of state law by the board of directors of
ViroPharma relating to the proposed buyout of the Company by Shire
Plc. The firm’s investigation seeks to determine, among other
things, whether the board of directors of ViroPharma breached their
fiduciary duties by failing to maximize shareholder value.
According to the press release announcing the proposed buyout,
ViroPharma shareholders will receive $50.00 per share in cash for
each share of ViroPharma common stock they own.
If you currently own common stock of ViroPharma and would like
to learn more about the investigation being conducted by Brower
Piven, you may email or call Brower Piven, who will, without
obligation or cost to you, attempt to answer your questions. You
may contact Brower Piven by email at hoffman@browerpiven.com, by
calling (410) 415-6616, or at Brower Piven, A Professional
Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153.
Attorneys at Brower Piven have combined experience litigating
securities and other class action cases of over 60 years.
Brower Piven, A Professional CorporationStevenson,
MarylandCharles J. Piven, 410-415-6616hoffman@browerpiven.com
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Viropharma Incorporated (MM) (NASDAQ:VPHM)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Viropharma Incorporated (MM) (NASDAQ): 0 recent articles
More Viropharma Incorporated (MM) News Articles